重症患者毛细血管渗漏的诊断:一种无创检测的新型评分工具的研发
该单中心、观察性、多学科前瞻性研究纳入两个独立运行的外科ICU的200例外科患者和30名健康志愿者,由两名ICU主治医师根据水肿程度、血管内容量不足、血流动力学不稳定和液体正平衡将患者临床分为CLS组与No-CLS组(各N=100)。通过每日无创生物电阻抗分析、超声和血清生物标志物检测,构建了包含7项参数(回声性、SOFA评分、血管生成素-2、多配体蛋白聚糖-1、ICAM-1、乳酸和白细胞介素-6)的CLS评分,随机森林预测模型将诊断性能提升至AUC 0.963(P < 0.001),两参数决策树模型AUC为0.865。CLS组30天死亡率升高(12% vs 1%,P = 0.002),SOFA评分更高,细胞外水增加,皮下组织回声性更高[29(24-31) vs 19(16-21),P < 0.001],血管生成素-2浓度升高[9.9(6.2-17.3) vs 3.7(2.6-5.6) ng/mL,P < 0.001]。作者认为CLS诊断可行,简化两参数方法可增强临床实用性,CLS导致死亡率升高,应归类为独立疾病实体。
要点
- CLS组30天死亡率12% vs No-CLS组1%(P = 0.002),且SOFA评分更高。
- CLS组细胞外水增加,皮下组织回声性更高[29(24-31) vs 19(16-21),P < 0.001]。
- CLS组血管生成素-2浓度升高[9.9(6.2-17.3) vs 3.7(2.6-5.6) ng/mL,P < 0.001]。
- 7参数CLS评分联合随机森林模型诊断AUC 0.963(P < 0.001),两参数决策树模型AUC 0.865。
- 作者认为CLS诊断可行,简化两参数方法可增强临床实用性,CLS应归类为独立疾病实体。
适用人群与场景
- 入住两个独立运行的外科ICU的外科患者200例,以及健康志愿者30名。
- 临床分组由两名具有>10年ICU经验的主治医师根据水肿程度、血管内容量不足、血流动力学不稳定和液体正平衡判定为CLS或No-CLS(各N=100)。
诊断标准与关键阈值
- CLS临床诊断依据:水肿程度、血管内容量不足、血流动力学不稳定和液体正平衡,由两名独立的主治医师判定。
- CLS评分包含7项参数:回声性、SOFA评分、血管生成素-2、多配体蛋白聚糖-1、ICAM-1、乳酸和白细胞介素-6。
- 随机森林预测模型诊断CLS的AUC为0.963(P < 0.001)。
- 两参数决策树模型诊断CLS的AUC为0.865。
研究设计与关键结果
- 研究类型:单中心、观察性、多学科、前瞻性试验,在两个独立运行的外科ICU进行;纳入200例外科患者和30名健康志愿者。
- CLS组30天死亡率12% vs No-CLS组1%(P = 0.002),CLS组SOFA评分更高。
- CLS组细胞外水增加,皮下组织回声性更高[29(24-31) vs 19(16-21),P < 0.001]。
- CLS组血管生成素-2浓度升高[9.9(6.2-17.3) vs 3.7(2.6-5.6) ng/mL,P < 0.001]。
- 7参数CLS评分的随机森林预测模型AUC 0.963(P < 0.001),两参数决策树模型AUC 0.865。
证据类型、等级与局限
- 证据类型:单中心、观察性、多学科、前瞻性试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,重症患者CLS的诊断可通过客观、无创参数构成的CLS评分实现。
- 作者认为,简化的两参数诊断方法可增强临床实用性。
- 作者认为,CLS导致死亡率升高,应归类为独立疾病实体。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The concomitant occurrence of the symptoms intravascular hypovolemia, peripheral edema and hemodynamic instability is typically named Capillary Leak Syndrome (CLS) and often occurs in surgical critical ill patients. However, neither a unitary definition nor standardized diagnostic criteria exist so far. We aimed to investigate common characteristics of this phenomenon with a subsequent scoring system, determining whether CLS contributes to mortality.
METHODS: We conducted this single-center, observational, multidisciplinary, prospective trial in two separately run surgical ICUs of a tertiary academic medical center. 200 surgical patients admitted to the ICU and 30 healthy volunteers were included. Patients were clinically diagnosed as CLS or No-CLS group (each N = 100) according to the grade of edema, intravascular hypovolemia, hemodynamic instability, and positive fluid balance by two independent attending physicians with > 10 years of experience in ICU. We performed daily measurements with non-invasive body impedance electrical analysis, ultrasound and analysis of serum biomarkers to generate objective diagnostic criteria. Receiver operating characteristics were used, while we developed machine learning models to increase diagnostic specifications for our scoring model.
RESULTS: The 30-day mortility was increased among CLS patients (12 vs. 1%, P = 0.002), while showing higher SOFA-scores. Extracellular water was increased in patients with CLS with higher echogenicity of subcutaneous tissue [29(24-31) vs. 19(16-21), P < 0.001]. Biomarkers showed characteristic alterations, especially with an increased angiopoietin-2 concentration in CLS [9.9(6.2-17.3) vs. 3.7(2.6-5.6)ng/mL, P < 0.001]. We developed a score using seven parameters (echogenicity, SOFA-score, angiopoietin-2, syndecan-1, ICAM-1, lactate and interleukin-6). A Random Forest prediction model boosted its diagnostic characteristics (AUC 0.963, P < 0.001), while a two-parameter decision tree model showed good specifications (AUC 0.865).
CONCLUSIONS: Diagnosis of CLS in critically ill patients is feasible by objective, non-invasive parameters using the CLS-Score. A simplified two-parameter diagnostic approach can enhance clinical utility. CLS contributes to mortality and should, therefore, classified as an independent entity.
TRIAL REGISTRATION: German Clinical Trials Registry (DRKS No. 00012713), Date of registration 10/05/2017, www.drks.de.
参考来源
- Wollborn J, Hassenzahl LO, Reker D, et al. Diagnosing capillary leak in critically ill patients: development of an innovative scoring instrument for non-invasive detection. Ann Intensive Care. 2021. PMID: 34910264. doi:10.1186/s13613-021-00965-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。